These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9112132)

  • 1. The cytotoxic interaction of inorganic trace elements with EDTA and cisplatin in sensitive and resistant human ovarian cancer cells.
    Maier RH; Purser SM; Nicholson DL; Pories WJ
    In Vitro Cell Dev Biol Anim; 1997 Mar; 33(3):218-21. PubMed ID: 9112132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of FTY720 with cisplatin exhibits antagonistic effects in ovarian cancer cells: role of autophagy.
    Zhang N; Dai L; Qi Y; Di W; Xia P
    Int J Oncol; 2013 Jun; 42(6):2053-9. PubMed ID: 23592281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
    Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
    Pavan S; Olivero M; Corà D; Di Renzo MF
    Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
    Shang X; Lin X; Manorek G; Howell SB
    Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis.
    Yamamoto K; Okamoto A; Isonishi S; Ochiai K; Ohtake Y
    Biochem Biophys Res Commun; 2001 Feb; 280(4):1148-54. PubMed ID: 11162647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative mapping of platinum and essential trace metal in cisplatin resistant and sensitive human ovarian adenocarcinoma cells.
    Ortega R; Moretto P; Fajac A; Benard J; Llabador Y; Simonoff M
    Cell Mol Biol (Noisy-le-grand); 1996 Feb; 42(1):77-88. PubMed ID: 8833669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trace element homeostasis during continuous sedation with propofol containing EDTA versus other sedatives in critically ill patients.
    Higgins TL; Murray M; Kett DH; Fulda G; Kramer KM; Gelmont D; Dedhia HV; Levy H; Teres D; Zaloga GP; Ko H; Thompson KA
    Intensive Care Med; 2000; 26 Suppl 4():S413-21. PubMed ID: 11310904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-fas antibody-mediated cytotoxicity and apoptosis.
    Uslu R; Jewett A; Bonavida B
    Gynecol Oncol; 1996 Aug; 62(2):282-91. PubMed ID: 8751562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
    Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-489 modulates cisplatin resistance in human ovarian cancer cells by targeting Akt3.
    Wu H; Xiao Z; Zhang H; Wang K; Liu W; Hao Q
    Anticancer Drugs; 2014 Aug; 25(7):799-809. PubMed ID: 24686007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisdioxopiperazine, (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187), enhances the antiproliferative effect of cisplatin on human ovarian cancer cells.
    Scambia G; Della Bitta R; Benedetti Panici P; De Vincenzo R; Contu G; Ercoli A; Bonanno G; Pierelli L; Mancuso S
    Gynecol Oncol; 1995 Apr; 57(1):16-22. PubMed ID: 7705696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of multidrug resistance in human lung cancer cells by delivery of 3-octadecylcarbamoylacrylic acid-cisplatin-based liposomes.
    Song J; Ren W; Xu T; Zhang Y; Guo H; Zhu S; Yang L
    Drug Des Devel Ther; 2017; 11():441-449. PubMed ID: 28255230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EDTA chelation effects on urinary losses of cadmium, calcium, chromium, cobalt, copper, lead, magnesium, and zinc.
    Waters RS; Bryden NA; Patterson KY; Veillon C; Anderson RA
    Biol Trace Elem Res; 2001 Dec; 83(3):207-21. PubMed ID: 11794513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt confers cisplatin chemoresistance in human gynecological carcinoma cells by modulating PPM1D stability.
    Ali AY; Kim JY; Pelletier JF; Vanderhyden BC; Bachvarov DR; Tsang BK
    Mol Carcinog; 2015 Nov; 54(11):1301-14. PubMed ID: 25154814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum.
    Uslu R; Bonavida B
    Cancer; 1996 Feb; 77(4):725-32. PubMed ID: 8616765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of suberoylanilide hydroxamic acid combined with cisplatin causing cell cycle arrest independent apoptosis in platinum-resistant ovarian cancer cells.
    Ong PS; Wang XQ; Lin HS; Chan SY; Ho PC
    Int J Oncol; 2012 May; 40(5):1705-13. PubMed ID: 22328352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
    Basu A; Weixel K; Saijo N
    Cell Growth Differ; 1996 Nov; 7(11):1507-12. PubMed ID: 8930400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high nuclear basal level of ERK2 phosphorylation contributes to the resistance of cisplatin-resistant human ovarian cancer cells.
    Lee S; Yoon S; Kim DH
    Gynecol Oncol; 2007 Feb; 104(2):338-44. PubMed ID: 17023032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.